A recent study demonstrated that metformin reduced the expression of progerin, a truncated form of prelamin A, by inhibiting the serine–arginine‐rich splicing factor SRSF1 in MSCs derived from patients with HGPS (Egesipe et al., 2016). The gene discussed is LMNA; the disease is Hutchinson-Gilford progeria syndrome.